About this trial
screen for neurologic and psychiatric disorders in children and
adolescents with IBD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with IBD aged from from 1 to18 years old.
Disqualifiers
patients with IBD and aged above 18 years old or below 1 year old
Trial population
Children diagnosed with inflammatory bowel disease in Assiut university child hospital
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Screening for Neurological manifestations among children diagnosed with inflammatory bowel disease in Assiut university children hospital
Neurologic symptoms have a great importance in early diagnosis and treatment preventing major morbidity and later sequelae, especially if they precede GI symptoms The prevalence of neurologic manifestations of IBD varies between 0.2% and 36%. Their pathogenesis of neurologic manifestations in IBD consists of 6 mechanisms: 1.malabsorption and nutritional deficiency 2.metabolic agents 3.infections complicating immune suppression 4.side effects of medications or iatrogenic as a surgical complication 5.thromboembolism 6.immunological factors UC patients are similar to or higher than CD patients in the probability of neurologic symptoms. Neurologic manifestations and complications include: headache, dizziness, hypotonia, ADHD, tics, sensory complaints, seizures, neuropsychiatric disorders, peripherial neuropathy, meningitis, vestibular dysfunction, idiopathic IC hypertension, cerebral vasculitis, demyelinating disorders and migraine
screen for neurologic and psychiatric disorders in children and adolescents with IBD.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Bishoy Shehata Fahim
Lead sponsor
Assiut University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: